| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 分子生物产品(元) | 311,415.91 | 116,814.14 | 8,263,353.97 | 8,005,101.76 |
| 干粉培养基(元) | 19,035,126.01 | 10,049,449.85 | 32,707,750.00 | 19,297,915.94 |
| 生物药品加工及技术服务(元) | 848,072.77 | 160,648.86 | 2,589,822.27 | 2,101,084.90 |
| 液体培养基(元) | 18,847,956.13 | 8,362,471.96 | 15,296,967.76 | 12,177,802.92 |
| 预灌装平皿培养基(元) | 13,507,516.89 | 6,458,202.91 | 14,854,306.35 | 6,651,668.36 |
| 增菌培养基(元) | 2,710,235.33 | 1,398,207.41 | 2,751,602.14 | 1,284,893.13 |
| 租赁收入(元) | 88,073.40 | 44,036.70 | 88,073.40 | 44,036.70 |
| 其他生物试剂(元) | 9,426,150.86 | 4,849,478.57 | 15,645,908.39 | 4,727,570.90 |
| 营业成本(元) | ||||
| 分子生物产品(元) | 108,632.13 | 49,633.47 | 856,692.89 | 716,139.49 |
| 干粉培养基(元) | 3,971,541.85 | 1,851,975.06 | 6,131,548.66 | 3,295,831.90 |
| 生物药品加工及技术服务(元) | 76,563.38 | 13,236.30 | 139,384.85 | 70,197.10 |
| 液体培养基(元) | 6,315,088.35 | 2,957,329.64 | 6,892,972.69 | 3,519,242.33 |
| 预灌装平皿培养基(元) | 6,565,980.39 | 2,978,629.83 | 6,928,908.00 | 3,199,382.03 |
| 增菌培养基(元) | 1,937,973.47 | 945,807.28 | 1,815,759.60 | 866,496.67 |
| 租赁收入(元) | 26,292.90 | 11,972.25 | 24,409.89 | 11,565.03 |
| 其他生物试剂(元) | 2,468,504.48 | 1,218,287.90 | 3,378,164.82 | 1,252,832.08 |
| 毛利(元) | ||||
| 分子生物产品(元) | 202,783.78 | 67,180.67 | 7,406,661.08 | 7,288,962.27 |
| 干粉培养基(元) | 15,063,584.16 | 8,197,474.79 | 26,576,201.34 | 16,002,084.04 |
| 生物药品加工及技术服务(元) | 771,509.39 | 147,412.56 | 2,450,437.42 | 2,030,887.80 |
| 液体培养基(元) | 12,532,867.78 | 5,405,142.32 | 8,403,995.07 | 8,658,560.59 |
| 预灌装平皿培养基(元) | 6,941,536.50 | 3,479,573.08 | 7,925,398.35 | 3,452,286.33 |
| 增菌培养基(元) | 772,261.86 | 452,400.13 | 935,842.54 | 418,396.46 |
| 租赁收入(元) | 61,780.50 | 32,064.45 | 63,663.51 | 32,471.67 |
| 其他生物试剂(元) | 6,957,646.38 | 3,631,190.67 | 12,267,743.57 | 3,474,738.82 |
| 毛利率(%) | ||||
| 分子生物产品(%) | 65.12 | 57.51 | 89.63 | 91.05 |
| 干粉培养基(%) | 79.14 | 81.57 | 81.25 | 82.92 |
| 生物药品加工及技术服务(%) | 90.97 | 91.76 | 94.62 | 96.66 |
| 液体培养基(%) | 66.49 | 64.64 | 54.94 | 71.10 |
| 预灌装平皿培养基(%) | 51.39 | 53.88 | 53.35 | 51.90 |
| 增菌培养基(%) | 28.49 | 32.36 | 34.01 | 32.56 |
| 租赁收入(%) | 70.15 | 72.81 | 72.28 | 73.74 |
| 其他生物试剂(%) | 73.81 | 74.88 | 78.41 | 73.50 |
| 收入构成(%) | ||||
| 分子生物产品(%) | 0.48 | 0.37 | 8.96 | 14.75 |
| 干粉培养基(%) | 29.39 | 31.96 | 35.48 | 35.55 |
| 生物药品加工及技术服务(%) | 1.31 | 0.51 | 2.81 | 3.87 |
| 液体培养基(%) | 29.10 | 26.60 | 16.59 | 22.43 |
| 预灌装平皿培养基(%) | 20.85 | 20.54 | 16.11 | 12.25 |
| 增菌培养基(%) | 4.18 | 4.45 | 2.98 | 2.37 |
| 租赁收入(%) | 0.14 | 0.14 | 0.10 | 0.08 |
| 其他生物试剂(%) | 14.55 | 15.42 | 16.97 | 8.71 |
| 毛利构成(%) | ||||
| 分子生物产品(%) | 0.47 | 0.31 | 11.22 | 17.62 |
| 干粉培养基(%) | 34.79 | 38.28 | 40.25 | 38.69 |
| 生物药品加工及技术服务(%) | 1.78 | 0.69 | 3.71 | 4.91 |
| 液体培养基(%) | 28.94 | 25.24 | 12.73 | 20.94 |
| 预灌装平皿培养基(%) | 16.03 | 16.25 | 12.00 | 8.35 |
| 增菌培养基(%) | 1.78 | 2.11 | 1.42 | 1.01 |
| 租赁收入(%) | 0.14 | 0.15 | 0.10 | 0.08 |
| 其他生物试剂(%) | 16.07 | 16.96 | 18.58 | 8.40 |